This new mobile app brings many benefits, including:
- View course lectures
- Read course materials
- Send and receive messages
- Check grades
- Receive notifications
“The demand for online learning has grown in continuing and higher education, and a massive uptick in virtual learning this year can be attributed to the COVID-19 pandemic,” says Diederik Van Niekerk, Senior Manager of South African Operations, MMS Holdings. “This digital innovation was a simple way to help further the educational goals of working professionals, as well as students looking for a stable, growing career in the pharmaceutical industry.”
According to a 2019 report from Wiley, approximately 56 percent of online college students used a smartphone or tablet to complete at least some of their online course-related activities. Released to a test group last month, users found the mobile app to be convenient, allowing easy access to courses and more efficient communication when staying in touch.
One MMS Academy student noted, “I truly enjoyed using the mobile app on my tablet to listen to the recordings. It worked perfectly, fitting into my lifestyle, and I was able to listen when convenient for me.”
The app is powered by Canvas, an online learning platform used by k-12, higher education, and corporate learning users, alike. Canvas allows for students, working professionals, faculty, and staff to communicate in an easily accessible virtual setting to create a more conducive environment for learning.
Sign-up for courses in the areas of medical writing, clinical trial transparency, clinical programming, and medical coding now by visiting https://mmsacademy.com. Use the code Accelerate50 at checkout for 50 percent off your first course, valid until December 31, 2020.
About MMS Holdings
MMS is an innovative, data-focused CRO that supports the pharmaceutical, biotech, and medical device industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience, technology-enabled services, and a data-driven approach to drug development make MMS a valuable CRO partner, creating compelling submissions that meet rigorous regulatory standards. With a global footprint across four continents, MMS maintains a 97 percent customer satisfaction rating, and the company has been recognized as a leading CRO in Global Health & Pharma’s international awards programs for the last three consecutive years. For more information, visit www.mmsholdings.com or follow MMS on LinkedIn.